CRSP - Crispr Therapeutics AG - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - CRSP (1674416)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
74 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P9+5+11+20+13
S10-0+0+0+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2018-05-15
CRSPBolzon Bradley J PhdDirS - Sale$57.99-44,000674,759-6%-$2,551,440
2018-05-15
CRSPWoiwode ThomasDirS - Sale$57.99-44,000645,643-6%-$2,551,440
M
2018-05-11
CRSPEmster Kurt VonDirS - Sale$54.39-650,0001,237,202-34%-$35,352,456
M
2018-05-07
CRSPWoiwode ThomasDirS - Sale$50.39-121,36296,359-56%-$6,115,873
M
2018-05-07
CRSPBolzon Bradley J PhdDirS - Sale$50.39-128,950125,475-51%-$6,497,892
2018-04-30
CRSPWoiwode ThomasDirS - Sale$50.29-30,566106,018-22%-$1,537,138
2018-04-30
CRSPBolzon Bradley J PhdDirS - Sale$50.29-30,566142,722-18%-$1,537,138
M
2018-04-26
CRSPBolzon Bradley J PhdDirS - Sale$50.11-222,258100,780-69%-$11,136,437
M
2018-04-26
CRSPWoiwode ThomasDirS - Sale$50.11-222,258100,780-69%-$11,136,437
2018-04-24
CRSPWoiwode ThomasDirS - Sale$50.99-22,841115,645-16%-$1,164,655
2018-04-24
CRSPBolzon Bradley J PhdDirS - Sale$50.99-22,841115,645-16%-$1,164,655
2018-04-24
CRSPVersant Venture Capital V, L.P.10%S - Sale$50.99-22,841115,645-16%-$1,164,655
2018-04-23
CRSPVersant Venture Capital Iv, L.P.10%S - Sale$50.68-101,994117,173-47%-$5,168,901
2018-04-23
CRSPWoiwode ThomasDirS - Sale$50.68-101,994124,455-45%-$5,168,901
2018-04-23
CRSPBolzon Bradley J PhdDirS - Sale$50.68-101,994161,159-39%-$5,168,901
2018-01-05
CRSPBayer Aktiengesellschaft10%P - Purchase$22.75+527,4725,708,747+10%+$11,999,988
D
2018-01-16
CRSPDylan-Hyde TylerGCS - Sale+OE$28.03-66,00025,204-72%-$1,850,255
2018-01-05
CRSPEmster Kurt VonDirP - Purchase$22.75+65,9341,887,202+4%+$1,499,999
2018-01-05
CRSPEmster Kurt VonDirS - Sale$26.96-92,3371,821,268-5%-$2,489,406
D
2018-01-02
CRSPDylan-Hyde TylerGCS - Sale+OE$21.64-38,00070,204-35%-$822,500
2018-01-02
CRSPEmster Kurt VonDirS - Sale$26.76-37,7541,913,605-2%-$1,010,123
DM
2017-12-28
CRSPDylan-Hyde TylerGCS - Sale+OE$22.72-31,000100,204-24%-$704,280
2017-12-22
CRSPDylan-Hyde TylerGCS - Sale$20.55-15,000115,204-12%-$308,250
2017-12-22
CRSPBolzon Bradley J PhdDirS - Sale$20.30-26,01627,724-48%-$528,237
2017-12-22
CRSPWoiwode ThomasDirS - Sale$20.29-3,0594,959-38%-$62,070
2017-12-15
CRSPDylan-Hyde TylerGCS - Sale$18.90-15,000130,204-10%-$283,496
EM
2017-11-03
CRSPCelgene Corp /de/10%S - Sale$18.98-1,112,4463,722,534-23%-$21,118,120
M
2017-11-24
CRSPWoiwode ThomasDirS - Sale$20.21-1,9008,018-19%-$38,406
M
2017-11-24
CRSPBolzon Bradley J PhdDirS - Sale$20.21-1,70753,740-3%-$34,498
DM
2017-08-31
CRSPNovak RodgerCEOS - Sale+OE$20.76-18,4701,148,007-2%-$383,393
DM
2017-08-28
CRSPNovak RodgerCEOS - Sale+OE$20.25-75,7951,162,624-6%-$1,534,869
M
2017-08-28
CRSPKulkarni SamarthChief Business OfficerS - Sale$20.08-27,154106,893-20%-$545,162
2017-08-28
CRSPEmster Kurt VonDirS - Sale$19.79-88,0111,951,359-4%-$1,741,738
M
2017-08-24
CRSPEmster Kurt VonDirS - Sale$19.42-22,7812,039,370-1%-$442,403
M
2017-08-22
CRSPEmster Kurt VonDirS - Sale$18.53-17,9892,062,151-1%-$333,336
M
2017-08-18
CRSPEmster Kurt VonDirS - Sale$18.52-3,1502,080,1400%-$58,345
M
2017-08-16
CRSPEmster Kurt VonDirS - Sale$19.06-34,1412,083,290-2%-$650,693
M
2017-08-14
CRSPEmster Kurt VonDirS - Sale$19.59-55,5692,117,431-3%-$1,088,561
M
2017-08-07
CRSPEmster Kurt VonDirS - Sale$18.63-35,4732,190,872-2%-$660,888
M
2017-08-04
CRSPDylan-Hyde TylerGCS - Sale$18.57-15,000153,204-9%-$278,479
M
2017-08-03
CRSPEmster Kurt VonDirS - Sale$17.81-50,4772,226,345-2%-$899,216
M
2017-07-31
CRSPEmster Kurt VonDirS - Sale$17.51-5,5122,276,8220%-$96,491
M
2017-07-27
CRSPEmster Kurt VonDirS - Sale$17.63-41,3122,282,334-2%-$728,134
M
2017-07-25
CRSPEmster Kurt VonDirS - Sale$17.60-32,9302,323,646-1%-$579,545
M
2017-07-13
CRSPEmster Kurt VonDirS - Sale$16.84-69,8592,356,576-3%-$1,176,710
M
2017-07-11
CRSPEmster Kurt VonDirS - Sale$16.56-31,9922,408,563-1%-$529,938
2017-07-05
CRSPEmster Kurt VonDirS - Sale$16.26-4,2542,440,5550%-$69,170
M
2017-06-28
CRSPEmster Kurt VonDirS - Sale$16.90-43,2022,444,809-2%-$730,125
M
2017-06-26
CRSPEmster Kurt VonDirS - Sale$17.08-81,4352,488,011-3%-$1,390,611
M
2017-06-22
CRSPEmster Kurt VonDirS - Sale$16.23-32,3682,569,446-1%-$525,302
D
2017-06-22
CRSPNovak RodgerCEOS - Sale+OE$15.37-10,8251,215,005-1%-$166,388
DM
2017-06-19
CRSPNovak RodgerCEOS - Sale+OE$15.01-30,2221,215,005-2%-$453,511
DM
2017-06-08
CRSPNovak RodgerCEOS - Sale+OE$15.02-5,3031,215,0050%-$79,628
D
2017-05-30
CRSPNovak RodgerCEOS - Sale+OE$15.02-3,6501,215,0050%-$54,829
DM
2017-05-16
CRSPNovak RodgerCEOS - Sale+OE$16.26-50,0001,215,005-4%-$812,859
D
2017-05-05
CRSPNovak RodgerCEOS - Sale+OE$16.92-6161,215,0050%-$10,4260
DM
2017-05-02
CRSPNovak RodgerCEOS - Sale+OE$16.30-49,3841,215,005-4%-$805,183+2+2
2017-05-01
CRSPDylan-Hyde TylerGCS - Sale$16.61-1,852168,204-1%-$30,753+3+4
DM
2017-04-26
CRSPKulkarni SamarthChief Business OfficerS - Sale+OE$16.76-5,481134,047-4%-$91,8390-2
M
2017-04-26
CRSPDylan-Hyde TylerGCS - Sale$16.78-21,639170,056-11%-$363,0770-2
M
2017-04-21
CRSPDylan-Hyde TylerGCS - Sale$16.78-11,332183,695-6%-$190,109-1+1
DM
2017-04-21
CRSPKulkarni SamarthChief Business OfficerS - Sale+OE$16.78-11,615134,047-8%-$194,942-1+1
DM
2017-04-19
CRSPNovak RodgerCEOS - Sale+OE$17.88-50,0001,215,005-4%-$893,918-20
DM
2017-04-19
CRSPKulkarni SamarthChief Business OfficerS - Sale+OE$17.73-10,058134,047-7%-$178,376-20
M
2017-04-19
CRSPDylan-Hyde TylerGCS - Sale$17.71-10,177195,027-5%-$180,190-20
D
2016-10-24
CRSPEmster Kurt VonDirP - Purchase$14.00+56,0002,601,814+2%+$784,000+9+24+42
D
2016-10-24
CRSPLundberg Sven AnteChief Scientific OfficerP - Purchase$14.00+4001,010,8340%+$5,600+2+25+43
AD
2016-10-24
CRSPVersant Venture Capital Iv, L.P.10%P - Purchase$14.00+161,00079,478-197%+$2,254,000+1-3-10
D
2016-10-24
CRSPWoiwode ThomasDirP - Purchase$14.00+161,000763,492+27%+$2,254,000+1-3-10
D
2016-10-24
CRSPBolzon Bradley J PhdDirP - Purchase$14.00+161,000763,492+27%+$2,254,000+1-3-10
AD
2016-10-24
CRSPCelgene Corp /de/10%P - Purchase$14.00+800,1504,834,980+20%+$11,202,100+6-3+31+8
D
2016-10-24
CRSPGeorge SimeonDirP - Purchase$14.00+66,5003,220,627+2%+$931,000+7+22+31+15
D
2016-10-24
CRSPGlaxosmithkline Plc10%P - Purchase$14.00+66,5003,220,627+2%+$931,000+7+22+31+15
D
2016-10-24
CRSPCelgene Corp /de/10%P - Purchase$14.00+800,1504,834,980+20%+$11,202,100+7+22+31+15

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top